Cargando…
Novel CFTR Activator Cact-3 Ameliorates Ocular Surface Dysfunctions in Scopolamine-Induced Dry Eye Mice
Cystic fibrosis transmembrane conductance regulator (CFTR) is highly expressed on the ocular epithelium and plays a pivotal role in the fluid secretion driven by chloride transport. Dry eye disease is one of the most common diseases with limited therapeutic options. In this study, a high-throughput...
Autores principales: | Jeon, Dongkyu, Jun, Ikhyun, Lee, Ho K., Park, Jinhong, Kim, Bo-Rahm, Ryu, Kunhi, Yoon, Hongchul, Kim, Tae-im, Namkung, Wan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101838/ https://www.ncbi.nlm.nih.gov/pubmed/35563597 http://dx.doi.org/10.3390/ijms23095206 |
Ejemplares similares
-
Isorhamnetin Ameliorates Dry Eye Disease via CFTR Activation in Mice
por: Lee, Ho K., et al.
Publicado: (2021) -
Synthetic Strategies
for Improving Solubility: Optimization
of Novel Pyrazolo[1,5-a]pyrimidine CFTR Activator
That Ameliorates Dry Eye Disease
por: Kim, Bo Yi, et al.
Publicado: (2022) -
VI-116, A Novel Potent Inhibitor of VRAC with Minimal Effect on ANO1
por: Jeon, Dongkyu, et al.
Publicado: (2022) -
α-Melanocyte-stimulating hormone ameliorates ocular surface dysfunctions and lesions in a scopolamine-induced dry eye model via PKA-CREB and MEK-Erk pathways
por: Ru, Yusha, et al.
Publicado: (2015) -
Inhibition of Aberrant α(1,2)-Fucosylation at Ocular Surface Ameliorates Dry Eye Disease
por: Yoon, Chang Ho, et al.
Publicado: (2021)